Page 95 - NobleCon19revC2_Neat

GeoVax Labs, Inc.

SELECTED FINANCIAL ITEMS GOVX

(in millions of USD)
CQ4 '22 CQ1 '23 CQ2 '23 CQ3 '23 LTM
Income Statement Key Items
Total Revenue 0.00 NA NA NA 0.00
Gross Profit (3.76) (2.82) (4.72) (6.95) (18.25)
Gross Margin NM NM NM NM NM
EBIT (5.39) (4.27) (6.18) (8.60) (24.44)
EBIT Margin NM NM NM NM NM
Net Income to Common Shareholders (5.38) (4.04) (5.93) (8.41) (23.76)
Net Margin NM NM NM NM NM

Balance Sheet Key Items
Total Assets 31.35 27.40 21.25 16.20 16.20
Cash & Short Term Investments 27.61 23.85 17.79 12.69 12.69
% of Assets 88% 87% 84% 78% 78%
Current Assets -Total 28.94 25.99 19.83 14.80 14.80
% of Assets 92% 95% 93% 91% 91%
Total Liabilities 4.75 4.54 4.09 7.08 7.08
% of Assets 15% 17% 19% 44% 44%
Current Liabilities - Total 4.75 4.54 4.09 7.08 7.08
% of Assets 15% 17% 19% 44% 44%
Long Term Debt NA NA NA NA NA
% of Assets NM NM NM NM NM
Total Equity 26.60 22.87 17.16 9.12 9.12
% of Assets 85% 83% 81% 56% 56%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (7.06) (3.76) (6.04) (5.10) (21.96)
Net Cash Flow - Investing 0.00 NA (0.02) (0.01) (0.03)
Net Cash Flow - Financing 0.00 NA NA NA 0.00

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Nineteenth Annual Small & Microcap Investor Conference